Drug Discovery & Development News: AI Innovations in Diagnosing Myopic Maculopathy & more...

Sat, 05 Oct 2024 20:28:43 -0700

Please click here to view this in your browser.

AI Innovations in Diagnosing Myopic Maculopathy

What methods can be developed to help identify symptoms of myopia and its more serious version, myopic maculopathy? This is what a recent study published in JAMA Ophthalmology hopes to address as an international team of researchers investigated how artificial intelligence (AI) algorithms can be used to identify ...

Uncovering a Mechanism of Immunotherapy Response in Lung Cancer

When cancer cells mutate, they produce small peptides called neoantigens. Because neoantigens remain relatively unique to tumors, they can provide a marker to help the immune system recognize and kill cancer cells. Research suggests that neoantigens can impact how well cancer treatments work, but the molecular ...

Study Attributes Improved Health-Related Quality of Life to Medical Cannabis Use

A study published in the Journal of Cannabis Research examined short-term changes in health-related quality of life (HRQoL) of medical cannabis patients over the first three months of medical cannabis consumption. The prospective, observational, longitudinal ...

Study Examines Frontal Lobe Functions of Male Cannabis Users

A study published in the Journal of Cannabis Research examined the residual neurocognitive effects of cannabis consumption. In particular, the Suez Canal University research team investigated whether the duration of cannabis use influences cognitive function before abstinence and how individuals assess their ...

UPCOMING WEBINARS

Development of an assay- and screening-platform to study molecular glue degraders

Dr. Melanie Meister - Senior Scientist II, AbbVie Deutschland GmbH & Co. KG

Dr. Johanna Huchting - Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Discovery Research ScreeningPort

Discover how targeting RNA-binding motif protein 39 (RBM39) is unlocking new possibilities in cancer treatment. RBM39, a key player in transcriptional regulation, alternative splicing, and protein translation, is critical to the growth of several cancers. Its inhibition has shown to be lethal in lung, breast, and colorectal cancers, making it a powerful emerging target for cancer diagnostics and ...

OCT 15, 2024 8:00 AM PDT

Accelerate research with high-throughput, automation-friendly gene expression analysis without RNA purification

Cindy Boardman - Scientist, R&D Sample Prep, Thermo Fisher Scientific

Luis McGregor - Staff Engineer, Systems Design, Thermo Fisher Scientific

To enhance productivity in research laboratories conducting genomic studies, automation techniques along with rapid workflows are encouraged. Here, we discuss gene expression analysis by reverse-transcription quantitative PCR (RT-qPCR) directly from cell lysates, removing the need to purify RNA with standard nucleic acid isolation techniques. We explore the benefits of removing gDNA during cell ...

OCT 17, 2024 8:00 AM PDT

See More Webinars

SCIENTIFIC PRODUCTS

AGILENT

Avida Methyl Reagent Kit

LEICA BIOSYSTEMS

Aperio VERSA

MAXCYTE

ExPERT ATx™ Small to medium scale static...

SARTORIUS

jetMESSENGER® mRNA transfection

BECKMAN COULTER LIFE SCIENCES